TMWM
BIOC

Taylor & Morgan Wealth Management’s Biocept, Inc. BIOC Stock Holding History

Taylor & Morgan Wealth Management’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-867
Closed -$8.84K – 68
2023
Q1 		$8.84K Hold
867
– – 0.01% 65
2022
Q4 		$13.8K Hold
867
– – 0.01% 66
2022
Q3 		$24K Hold
867
– – 0.02% 64
2022
Q2 		$24K Buy
867
+100
+13% +$4.55K 0.02% 66
2022
Q1 		$53K Buy
767
+367
+92% +$28.8K 0.04% 63
2021
Q4 		$43K Buy
+400
New +$46.1K 0.03% 67

Other funds holding BIOC

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Taylor & Morgan Wealth Management's BIOC Position: Q2 2023 in Review

Taylor & Morgan Wealth Management sold out of Biocept, Inc. (BIOC) in Q2 2023, closing a stake of 867 shares — an estimated $8.84K sold.

Taylor & Morgan Wealth Management first reported a position in BIOC in Q4 2021 and held it in 6 quarters. The position peaked at $53K in Q1 2022. 11 funds tracked by Wall St. Rank hold BIOC as of Q2 2023.

  • Taylor & Morgan Wealth Management reported no remaining Biocept, Inc. position as of Q2 2023 after selling out during the quarter.
  • Taylor & Morgan Wealth Management sold 867 Biocept, Inc. shares in Q2 2023, an estimated $8.84K.
  • Taylor & Morgan Wealth Management first reported a position in Biocept, Inc. in Q4 2021 and held it in 6 quarters.
  • Taylor & Morgan Wealth Management's Biocept, Inc. position peaked at $53K in Q1 2022.
  • 11 funds tracked by Wall St. Rank held Biocept, Inc. as of Q2 2023.

Based on Taylor & Morgan Wealth Management's 13F filing for Q2 2023, filed 13 Jul 2023.